Skip to main content
. 2023 Nov 6;10:1251905. doi: 10.3389/fmolb.2023.1251905

TABLE 2.

Correlation between compounds identified by metabolomic analysis and clinical parameters in the study group.

Compound Clinical parameter r p
LPC(20:0) HOMA −0.6967 0.0056
LPC(22:6) HOMA 0.6176 0.0186
LPC(O-16:1)/LPC(P-16:0) HOMA −0.7846 0.0009
LPC(O-18:0) HOMA −0.8198 0.0003
LPC(O-18:1)/LPC(P-18:0) HOMA −0.6703 0.0087
LPC(O-18:2)/LPC(P-18:1) HOMA −0.5824 0.0289
LPE(22:5) HOMA −0.7846 0.0009
LPE(22:6) HOMA 0.6044 0.0221
LPE(22:6) HOMA 0.5692 0.0336
PC(16:0/22:6) HOMA 0.7011 0.0052
PC(18:2/18:2) HOMA −0.5604 0.0371
PE(16:0/22:6) HOMA 0.6835 0.0070
PE(16:0/20:4) HOMA 0.5736 0.0320
ST19:1; O3; S HOMA 0.6615 0.0100
Leucine/Isoleucine HOMA 0.5692 0.0336
CAR (18:1) HOMA 0.6308 0.0156
LPC (O-16:1)/LPC (P-16:0) HOMA −0.7582 0.0017
LPC (O-16:0) HOMA −0.7802 0.0010
LPC (O-18:1)/LPC (P-18:O) HOMA −0.6659 0.0093
LPC (O-18:0) HOMA −0.8462 0.0001
LPE (22:6) HOMA 0.6088 0.0209
LPC (19:0) HOMA −0.5385 0.0470
PE (36:4) HOMA 0.5473 0.0428
PC (O-34:2)/PC (P-34:1) HOMA −0.5648 0.0353
PC (18:0/18:2(OH)) HOMA −0.8330 0.0002
PC (38:5) HOMA 0.6264 0.0165
PC (40:6) HOMA 0.7187 0.0038
LPC(O-18:0) Hba1c −0.5491 0.0420
LPC(O-18:2)/LPC(P-18:1) Hba1c −0.6461 0.0126
LPE(18:0) Hba1c 0.5976 0.0240
LPE(22:5) Hba1c −0.6924 0.0061
PE(16:0/20:4) Hba1c 0.5667 0.0346
SM(d32:2) Hba1c −0.6770 0.0078
trans-2-Dodecenoylcarnitine Hba1c 0.5954 0.0247
CAR (18:1) Hba1c 0.5380 0.0472
LPC (O-16:0) Hba1c −0.5821 0.0289
Ceramide (34:1) Hba1c 0.5601 0.0372
SM (d18:2/14:0) Hba1c −0.7409 0.0024
PE (36:4) Hba1c 0.6174 0.0186
PC (O-34:2)/PC (P-34:1) Hba1c −0.6659 0.0093
PC (18:0/18:2(OH)) Hba1c −0.5402 0.0461
LPC(19:0) C-peptide −0.5560 0.0389
LPC(20:0) C-peptide −0.5912 0.0260
LPC(O-16:1)/LPC(P-16:0) C-peptide −0.8198 0.0003
LPC(O-18:0) C-peptide −0.8462 0.0001
LPC(O-18:1)/LPC(P-18:0) C-peptide −0.5780 0.0304
LPC(O-18:2)/LPC(P-18:1) C-peptide −0.5341 0.0492
LPE(22:5) C-peptide −0.7143 0.0041
PC(18:2/20:4) C-peptide −0.5473 0.0428
PE(16:0/22:6) C-peptide 0.5868 0.0274
ST19:1; O3; S C-peptide 0.7011 0.0052
LPC (O-16:1)/LPC (P-16:0) C-peptide −0.7670 0.0014
LPC (O-16:0) C-peptide −0.6615 0.0100
LPC (O-18:1)/LPC (P-18:O) C-peptide −0.7099 0.0045
LPC (O-18:0) C-peptide −0.8593 0.0001
LPC (19:0) C-peptide −0.5692 0.0336
LPC (24:0) C-peptide −0.5473 0.0428
PC (18:0/18:2(OH)) C-peptide −0.7582 0.0017
PC (40:6) C-peptide 0.6747 0.0081
LPC(22:6) creatinine 0.5516 0.0408
LPE(18:0) creatinine 0.7363 0.0027
LPE(20:4) creatinine 0.6044 0.0221
LPE(22:6) creatinine 0.7538 0.0018
LPE(22:6) creatinine 0.7582 0.0017
PC(16:0/20:5) creatinine 0.5560 0.0389
PC(16:0/22:6) creatinine 0.6835 0.0070
PE(16:0/18:2) creatinine 0.5692 0.0336
PE(16:0/22:6) creatinine 0.6088 0.0209
Leucine/Isoleucine creatinine 0.5604 0.0371
CAR (18:1) creatinine 0.8813 0.0000
LPE (22:6) creatinine 0.7846 0.0009
Ceramide (34:1) creatinine 0.5385 0.0470
Hexacosanoyl carnitine creatinine 0.5516 0.0408
PC (18:0/18:2(OH)) creatinine −0.5648 0.0353
PC (20:5/16:0) creatinine −0.5385 0.0470
PC (40:6) creatinine 0.5341 0.0492
LPC(18:0) creatinine 0.5516 0.0408
LPC(20:1) creatinine 0.6879 0.0065
LPC(O-18:0) creatinine 0.6044 0.0221
PC(16:0/20:4) creatinine −0.6264 0.0165
Valine creatinine −0.6484 0.0121
Linoleamide creatinine −0.6396 0.0138
LPE (18:2) sn-2 creatinine 0.6044 0.0221
Hexacosanoyl carnitine creatinine 0.6088 0.0209
LPC (20:1) sn-2 creatinine 0.6000 0.0233
LPC (20:1) sn-1 creatinine 0.7011 0.0052